|
HSPA4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.978400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.000600E-01 |
| Normal-vs-Stage2 |
2.813000E-01 |
| Normal-vs-Stage3 |
2.045200E-01 |
| Normal-vs-Stage4 |
1.984050E-01 |
| Stage1-vs-Stage2 |
1.268370E-01 |
| Stage1-vs-Stage3 |
2.987800E-01 |
| Stage1-vs-Stage4 |
3.715400E-01 |
| Stage2-vs-Stage3 |
4.915700E-02 |
| Stage2-vs-Stage4 |
5.147900E-02 |
| Stage3-vs-Stage4 |
9.264200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.967200E-01 |
| Normal-vs-AfricanAmerican |
4.420400E-01 |
| Normal-vs-Asian |
3.792000E-01 |
| Caucasian-vs-AfricanAmerican |
2.014200E-01 |
| Caucasian-vs-Asian |
7.129200E-01 |
| AfricanAmerican-vs-Asian |
1.755770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.541800E-01 |
| Normal-vs-Female |
5.749800E-01 |
| Male-vs-Female |
9.116800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.682200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.552200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.271600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.463800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.081200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.338600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.461400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.433400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.272400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.684600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.327900E-02 |
| Classical-VS-Follicular |
1.303810E-01 |
| Classical-VS-Other |
1.031160E-01 |
| Classical-VS-Normal |
8.842000E-01 |
| Tall-VS-Follicular |
4.255000E-01 |
| Tall-VS-Other |
4.137600E-01 |
| Tall-VS-Normal |
7.996000E-02 |
| Follicular-VS-Other |
2.773600E-01 |
| Follicular-VS-Normal |
3.331000E-01 |
| Other-VS-Normal |
6.622000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.430800E-01 |
| Normal-vs-N1 |
7.747600E-02 |
| N0-vs-N1 |
1.807630E-01 |
|
|
